TRCT
HCA icon

Tower Research Capital (TRC)’s HCA Healthcare HCA Stock Holding History

Tower Research Capital (TRC)’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Sell
2,354
-1,522
-39% -$766K 0.03% 495
2025
Q4 		$1.81M Sell
3,876
-6,732
-63% -$3.13M 0.04% 360
2025
Q3 		$4.52M Buy
10,608
+6,224
+142% +$2.41M 0.12% 137
2025
Q2 		$1.68M Sell
4,384
-2,375
-35% -$856K 0.05% 355
2025
Q1 		$2.34M Sell
6,759
-4,376
-39% -$1.41M 0.07% 244
2024
Q4 		$3.34M Buy
11,135
+5,469
+97% +$1.91M 0.07% 233
2024
Q3 		$2.3M Sell
5,666
-17,466
-76% -$6.39M 0.06% 241
2024
Q2 		$7.43M Buy
23,132
+16,806
+266% +$5.46M 0.13% 131
2024
Q1 		$2.11M Sell
6,326
-18,538
-75% -$5.66M 0.05% 275
2023
Q4 		$6.73M Buy
24,864
+18,835
+312% +$4.66M 0.08% 195
2023
Q3 		$1.48M Buy
6,029
+2,511
+71% +$687K 0.05% 400
2023
Q2 		$1.07M Sell
3,518
-3,014
-46% -$838K 0.04% 478
2023
Q1 		$1.72M Buy
6,532
+1,675
+34% +$425K 0.05% 232
2022
Q4 		$1.17M Sell
4,857
-15,376
-76% -$3.44M 0.05% 326
2022
Q3 		$3.72M Buy
20,233
+3,735
+23% +$744K 0.06% 252
2022
Q2 		$2.77M Sell
16,498
-21,899
-57% -$4.7M 0.06% 268
2022
Q1 		$9.62M Buy
38,397
+23,070
+151% +$5.79M 0.09% 191
2021
Q4 		$3.94M Buy
15,327
+10,390
+210% +$2.54M 0.07% 244
2021
Q3 		$1.2M Sell
4,937
-3,266
-40% -$798K 0.03% 451
2021
Q2 		$1.7M Sell
8,203
-14,769
-64% -$3.01M 0.04% 371
2021
Q1 		$4.33M Buy
22,972
+11,962
+109% +$2.11M 0.07% 248
2020
Q4 		$1.81M Buy
11,010
+3,516
+47% +$514K 0.06% 249
2020
Q3 		$934K Buy
7,494
+2,973
+66% +$368K 0.01% 1070
2020
Q2 		$439K Buy
4,521
+4,424
+4,561% +$460K 0.02% 1136
2020
Q1 		$9K Sell
97
-120
-55% -$15.5K ﹤0.01% 2072
2019
Q4 		$32K Sell
217
-8,102
-97% -$1.09M ﹤0.01% 1621
2019
Q3 		$1M Buy
8,319
+3,381
+68% +$437K 0.07% 287
2019
Q2 		$668K Sell
4,938
-1,591
-24% -$201K 0.05% 368
2019
Q1 		$852K Sell
6,529
-3,649
-36% -$490K 0.05% 345
2018
Q4 		$1.27M Buy
10,178
+9,151
+891% +$1.23M 0.09% 212
2018
Q3 		$143K Sell
1,027
-8,741
-89% -$1.09M 0.01% 1160
2018
Q2 		$1M Buy
+9,768
New +$988K 0.06% 351
2018
Q1 		– Sell
-10,206
Closed -$897K – 3488
2017
Q4 		$897K Buy
10,206
+9,547
+1,449% +$767K 0.12% 181
2017
Q3 		$52K Buy
659
+249
+61% +$20K ﹤0.01% 1927
2017
Q2 		$36K Buy
410
+309
+306% +$26.1K ﹤0.01% 912
2017
Q1 		$9K Sell
101
-10,057
-99% -$839K ﹤0.01% 1844
2016
Q4 		$752K Buy
10,158
+4,382
+76% +$328K 0.08% 256
2016
Q3 		$437K Sell
5,776
-4,925
-46% -$377K 0.04% 192
2016
Q2 		$824K Buy
10,701
+8,429
+371% +$665K 0.08% 182
2016
Q1 		$177K Buy
2,272
+1,678
+282% +$117K 0.03% 347
2015
Q4 		$40K Buy
594
+141
+31% +$9.84K 0.01% 688
2015
Q3 		$35K Sell
453
-1,537
-77% -$136K ﹤0.01% 1271
2015
Q2 		$181K Buy
1,990
+99
+5% +$7.93K 0.02% 427
2015
Q1 		$142K Buy
1,891
+1,708
+933% +$123K 0.02% 614
2014
Q4 		$13K Buy
+183
New +$12.9K ﹤0.01% 1910
2014
Q3 		– Sell
-1,436
Closed -$81K – 4585
2014
Q2 		$81K Buy
1,436
+1,275
+792% +$67.3K 0.01% 1014
2014
Q1 		$8K Sell
161
-1,683
-91% -$83.8K ﹤0.01% 2822
2013
Q4 		$88K Buy
1,844
+284
+18% +$13.1K 0.01% 940
2013
Q3 		$67K Buy
1,560
+1,473
+1,693% +$57.6K 0.01% 1653
2013
Q2 		$3K Buy
+87
New +$3.37K ﹤0.01% 3286

Other funds holding HCA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Tower Research Capital (TRC)'s HCA Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its HCA Healthcare (HCA) stake by 39% in Q1 2026, selling an estimated $766K and leaving 2,354 shares worth $1.11M. The position accounts for 0.03% of the portfolio, ranked #495.

Tower Research Capital (TRC) first reported a position in HCA in Q2 2013 and has held it in 50 quarters since. The position peaked at $9.62M in Q1 2022. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Tower Research Capital (TRC) held 2,354 shares of HCA Healthcare worth $1.11M as of Q1 2026.
  • Tower Research Capital (TRC) sold 1,522 HCA Healthcare shares in Q1 2026, an estimated $766K.
  • HCA Healthcare made up 0.03% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #495 holding.
  • Tower Research Capital (TRC) first reported a position in HCA Healthcare in Q2 2013 and has held it in 50 quarters since.
  • Tower Research Capital (TRC)'s HCA Healthcare position peaked at $9.62M in Q1 2022.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.